These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31004342)

  • 21. An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands.
    Iwakiri J; Granbois K; Wehner N; Graves HC; Stamey T
    J Urol; 1993 Apr; 149(4):783-6. PubMed ID: 7681118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy. Prostate-specific antigen.
    Shinghal R; Yemoto C; McNeal JE; Brooks JD
    Urology; 2003 Feb; 61(2):380-5. PubMed ID: 12597952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'.
    Ahmed KA; Davis BJ; Mynderse LA; Slezak JM; Bergstralh EJ; Wilson TM; Choo CR
    Radiat Oncol; 2014 Jul; 9():171. PubMed ID: 25074478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate.
    Budäus L; Schiffmann J; Graefen M; Huland H; Tennstedt P; Siegmann A; Böhmer D; Budach V; Bartkowiak D; Wiegel T
    Strahlenther Onkol; 2017 Sep; 193(9):692-699. PubMed ID: 28470414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria.
    Gretzer MB; Trock BJ; Han M; Walsh PC
    J Urol; 2002 Oct; 168(4 Pt 1):1419-22. PubMed ID: 12352408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy.
    Yang X; Monn MF; Liu L; Liu Y; Su J; Lyu T; Gong Y; Wang L; Davidson DD; Cheng L
    Prostate; 2015 Jun; 75(8):845-54. PubMed ID: 25704311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum prostate-specific antigen value adjusted for non-cancerous prostate tissue volume in patients undergoing radical prostatectomy: a new predictor of biochemical recurrence in localized or locally advanced prostate cancer.
    Ku JH; Moon KC; Cho SY; Kwak C; Kim HH
    Asian J Androl; 2011 Mar; 13(2):248-53. PubMed ID: 21102474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study.
    Mizowaki T; Aoki M; Nakamura K; Yorozu A; Kokubo M; Karasawa K; Kozuka T; Nakajima N; Sasai K; Akimoto T
    J Radiat Res; 2015 Jul; 56(4):750-6. PubMed ID: 25910489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early prediction of prostate cancer biochemical recurrence and identification of disease persistence using PSA isoforms and human kallikrein-2.
    Do Carmo Silva J; Vesely S; Luksanova H; Prusa R; Babjuk M
    Tumour Biol; 2021; 43(1):197-207. PubMed ID: 34486998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial.
    Shin YS; Lee JW; Kim MK; Jeong YB; Park SC
    Investig Clin Urol; 2017 Mar; 58(2):98-102. PubMed ID: 28261678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen.
    Freedland SJ; Sutter ME; Dorey F; Aronson WJ
    Urology; 2003 Feb; 61(2):365-9. PubMed ID: 12597949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome.
    Vesely S; Jarolim L; Schmidt M; Minarik I; Dusek P; Babjuk M
    World J Urol; 2013 Apr; 31(2):299-304. PubMed ID: 22684375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy.
    Wang YJ; Huang CY; Hou WH; Wang CC; Lan KH; Yu HJ; Lai MK; Liu SP; Pu YS; Cheng JC
    Oncotarget; 2016 Jul; 7(28):44224-44235. PubMed ID: 27317764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.
    Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Sun LL; Moul JW; Freedland SJ
    Int J Urol; 2010 Nov; 17(11):914-22. PubMed ID: 20880361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidental prostate cancer in patients undergoing radical cystoprostatectomy for bladder cancer.
    Hiros M; Spahović H; Selimović M; Sadović S
    Bosn J Basic Med Sci; 2008 May; 8(2):147-51. PubMed ID: 18498265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [-2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report.
    De Luca S; Passera R; Sottile A; Fiori C; Scarpa RM; Porpiglia F
    BMC Urol; 2016 Mar; 16():14. PubMed ID: 27013515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation.
    Stokes SH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):129-36. PubMed ID: 10758314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
    Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
    Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.